Lakefront Biotherapeutics NV (G1LP34.SA) Q1 2025 Earnings

12FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-4.75
-2.5
-0.26
1.99

Details

Expected EPS
-3.049406434647512
Actual EPS
1.723516837983928
Surprise EPS
4.77
Surprise Percent
+156.52%

Description

Lakefront Biotherapeutics NV (G1LP34.SA) has reported earnings of 1.723516837983928 per share for Q1 2025.

0 Comments

Share your thoughts